Single Cell Analysis Global Market Opportunities and Strategies to 2032

This report describes and explains the single cell analysis market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global single cell analysis market reached a value of nearly $2.8 billion in 2022, having increased at a compound annual growth rate (CAGR) of 12.4% since 2017. The market is expected to grow from $2.8 billion in 2022 to $5.1 billion in 2027 at a rate of 12.8 %. The market is then expected to grow at a CAGR of 16.2% from 2027 and reach $10.8 billion in 2032.

Growth in the historic period resulted from strong economic growth in emerging markets, the rising advanced healthcare infrastructure and the rising healthcare expenditure. Factors that negatively affected growth in the historic period were regulatory challenges and high costs associated with the treatment of cancer.

Going forward, the increasing government support, the increasing cancer cases, aging population and the increase in healthcare access will drive the market. Factors that could hinder the growth of the single cell analysis market in the future include the rise in interest rates, reductions in free trade and the high cost of raw materials.

The single cell analysis market is segmented by type into consumables, instruments and services. The consumables market was the largest segment of the single cell analysis market by type, accounting for $1,456.6 million or 52.5% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 13.1 %.

The single cell analysis market is segmented by application into cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization and other applications. The cancer market was the largest segment of the single cell analysis market by application, accounting for $835.3 million or 30.1 % of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 13.3%.

The single cell analysis market is segmented by end user into academic and research laboratories, biotechnology and pharmaceutical companies, hospital and diagnostic laboratories and other end users. The academic and research laboratories market was the largest segment of the single cell analysis market by end user, accounting for $1.4 billion or 52.1% of the total market in 2022. The biotechnology and pharmaceutical companies market is expected to be the fastest-growing segment going forward at a CAGR of 13.4%.

The single cell analysis market is segmented by technique into flow cytometry, next generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry and other techniques. The next generation sequencing market was the largest segment of the single cell analysis market by technique, accounting for $694.0 million or 25.0% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 13.6%.

The single cell analysis market is segmented by end user workflow into single-cell isolation and library preparation, downstream analysis and data analysis. The single-cell isolation and library preparation market was the largest segment of the single cell analysis market by end user workflow, accounting for $2,012.7 million or 72.5% of the total market in 2022. The data analysis market is expected to be the fastest-growing segment going forward at a CAGR of 13.6%.

North America was the largest region in the single cell analysis market, accounting for 39.1 % of the global market in 2022. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the single cell analysis market will be the Middle East and the Western Europe, where growth will be at CAGRs of 15.4% and 14.3% respectively from 2022-2027.

The global single cell analysis market is highly concentrated, with a small number of players dominating the market. The top ten competitors in the market made up to 59.64% of the total market in 2022. The Becton, Dickinson, and Company was the largest competitor with 14.90% share of the market, followed by Merck KGaA with 13.25%, Illumina Inc. with 7.51%, Danaher Corporation with 6.34%, Bio-Rad Laboratories Inc. with 4.85%, Agilent Technologies Inc. with 4.33%, Sartorius AG with 3.55%, 10x Genomics with 1.86%, Qiagen NV with 1.83% and Thermo Fisher Scientific, Inc. with 1.22%.

The top opportunities in the single cell analysis market by type will arise in the consumables market, which will gain $1.2 billion of global annual sales by 2027. The top opportunities in the single cell analysis market by application will arise in cancer market, which will gain $724.0 million of global annual sales by 2027. The top opportunities in the single cell analysis market by end user will arise in academic and research laboratories market, which will gain $1.1 billion of global annual sales by 2027. The top opportunities in the single cell analysis market by technique will arise in next generation sequencing market, which will gain $617.7 million of global annual sales by 2027. The top opportunities in the single cell analysis market by end user workflow will arise in single-cell isolation and library preparation market, which will gain $1.6 billion of global annual sales by 2027. The single cell analysis market size will gain the most in the USA at $794.7 million.

Market-trend-based strategies for the single cell analysis market include focus on developing innovative products, advanced technologies such as artificial intelligence (AI), product innovations, new analysis modules, use of bioinformatics analysis tools, and partnerships and collaborations to improve their financial strength, product portfolio, and geographical presence.

Player-adopted strategies in the single cell analysis industry include enhancing business operations through the launch of new products and expanding operational capabilities through strategic acquisitions.

To take advantage of the opportunities, the recommends the single cell analysis companies to focus on product innovations, focus on technology advancements, focus on artificial intelligence, focus on use of bioinformatic analysis tools, focus on fast-growing techniques, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, and continue to target fast-growing end-users.